Skip to content
Use caution Drug recall · FDA · Published June 4, 2018

Hospira Naloxone Injection Recall: Particulate Matter Risk

Hospira recalls specific naloxone injection products due to potential particulate matter on syringes, which could cause serious injury if injected. Affected products include 1 mL cartridges and 10-count boxes with certain NDC numbers.

🇺🇸 FDA recall #D-0906-2018DrugHospira ›
Take action

Contact the company

Recalling firmHOSPIRA INC, LAKE FOREST275 NORTH FOREST DRIVE · LAKE FOREST, IL 60045
✎ GovInfoNow plain-language explainer

Hospira is recalling specific naloxone injection products that may contain particulate matter on the syringe plunger. This could lead to serious injury if the product is injected. The recall affects certain products sold with specific expiration dates and NDC numbers. Read more at govinfonow.com/recall/40500-hospira-naloxone-injection-recall-particulate-matter-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/40500-hospira-naloxone-injection-recall-particulate-matter-risk · Updated October 7, 2026 · FDA enforcement record: FDA #D-0906-2018

Cite this page

“Hospira Naloxone Injection Recall: Particulate Matter Risk.” GovInfoNow, updated October 7, 2026. https://govinfonow.com/recall/40500-hospira-naloxone-injection-recall-particulate-matter-risk. Based on FDA recall #D-0906-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0906-2018%22&limit=1).

The FDA announced on June 4, 2018, that Hospira Inc. of Lake Forest voluntarily recalled Naloxone Hydrochloride Injection USP due to the presence of particulate matter. The recall affects 164,860 syringes distributed nationwide in the U.S., Puerto Rico, and Guam.

How to tell if you have it

  • Brand: Hospira
  • Product: Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL Carpuject Single-use cartridge syringe, Single unit
  • NDC: 0409-1782-03 (Lot 72680LL, Exp. 1DEC2018)
  • NDC: 0409-1782-69 (Lot 76510LL, Exp. 1APR2019)

The hazard

According to the FDA, the hazard is the presence of particulate matter and potential for particulate matter on the syringe plunger.

Context

GovInfoNow's records show Hospira Inc. has one other recall on record since July 26, 2017. Other recent recalls of similar products include GE Healthcare Omnipaque Injection Recall (March 24, 2026), American Regent Tralement injection recall (July 24, 2026), and American Regent Papaverine HCl Injection Recall (July 24, 2026).

How to tell if you have this one

Check for the product name 'Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL Carpuject Single-use cartridge syringe' with NDC numbers 0409-1782-03 or 0409-1782-69. Products were sold with expiration dates of December 1, 2018, or April 1, 2019.

  • Brand
    Hospira
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for the NDC numbers 0409-1782-03 or 0409-1782-69 on the product label.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Nationwide in the U.S., Puerto Rico, and Guam” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 22 months after the firm started it.

1. Firm started the recall: Jun 4, 201812. Published in FDA’s Enforcement Report: Jun 13, 201823. FDA classified it Class I: Jul 2, 201834. FDA terminated the recall: Mar 27, 2020420182020
  1. Firm started the recall
  2. Published in FDA’s Enforcement Report
  3. FDA classified it Class I
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Is this product safe to use?

The recall indicates a potential risk of particulate matter, so it is not safe to use until the product is replaced with a confirmed safe version.

What should I do if I have this product?

Contact Hospira directly to determine if your product is affected and follow their instructions for replacement or disposal.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0906-2018 (June 4, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0906-2018 to see it in context.
  • Plain-language summary written by qwen3:4b on October 7, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA